Global topiramate (cas 97240 79 4) market unimark remedies (india), janssen pharmaceutica (belgium),

Page 1

12/10/2016 Global Topiramate (CAS 97240­79­4) Market­Unimark Remedies (India), Janssen Pharmaceutica (Belgium), Taj Pharmaceuticals (India) ­ openPR

Home

Categories

Submit Press Release

Order Credits

Archive

11­16­2016 06:51 PM CET ­ Health & Medicine

News / Feeds

Print

PDF

About Us

GO

Search

Global Topiramate (CAS 97240­79­4) Market­Unimark Remedies (India), Janssen Pharmaceutica (Belgium), Taj Pharmaceuticals (India) More Releases from Market News

Press release from: Market News

Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss. The drug had previously been used off­label for this purpose. Topiramate was originally produced by Ortho­McNeil Neurologics and Noramco, Inc., both divisions of the Johnson & Johnson Corporation. This medication was discovered in 1979 by Bruce E. Maryanoff and Joseph F. Gardocki during their research work at McNeil Pharmaceutical. Major players in the global Topiramate (CAS 97240­79­4) market :­ Unimark Remedies (India) Janssen Pharmaceutica (Belgium) Taj Pharmaceuticals (India) ScinoPharm (Taiwan)

Global Ketoprofen Market Taj Pharmaceuticals India Century Pharmaceuticals India BEC Chemicals India Global Carbamazepine CBZ Market Novartis Pharma Switzerland Taj Pharmaceuticals India Jubilant Pharma India Zhejiang Jiuzhou China Global Nitrile Butadiene Rubber NBR Market LANXESS Germany Zeon Japan CNPC China NANTEX Taiwan KUMHO Korea LG Korea All 5 Releases

Request for sample @ goo.gl/crjaq5 This report provides detailed analysis of worldwide markets for Topiramate (CAS 97240­79­4) from 2011­ 2015 and provides extensive market forecasts 2016­2021 by region/country and sub sectors. It covers the key technological and market trends in the Topiramate (CAS 97240­79­4) market and further lays out an analysis of the factors influencing the supply/demand for Topiramate (CAS 97240­79­4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. Global Topiramate (CAS 97240­79­4) Market Outlook 2016­2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Topiramate (CAS 97240­79­4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.

Comments about openPR 9 o'clock: discuss press release with client 10 o'clock: submit release to openPR Within the briefest possible time release is published and displayed in a prominent place on openPR.de. I am thrilled! Zehra Spindler, Calypso Now! ­ Communication Agency

Your Press Releases on Google News

Browe full report With TOC: marketinsights.biz/global­topiramate­cas­97240­79­4­marke... The report provides separate comprehensive analytics for the North America, Europe, Asia­Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Topiramate (CAS 97240­79­4) industry has been provided.

openPR.de

"MarketInsights.Biz” offer reports from top publishers and update to serve you with immediate on­line access to professional insights on global industries, companies, products, and trends. Customers can buys different reports across various categories such as Chemical and Material, Biotechnology, Healthcare, Food and beverages, Automobile and various sectors. Our Website offers safe and secure online ordering experience, convenient payment options. Contact US: Frank Valadez Director of Business Development Website: marketinsights.biz/ Email:sales@marketinsights.biz This release was published on openPR.

News­ID: 383520 More releases

Permanent link to this press release: http://www.openpr.com/news/383520/Global­Topiramate­CAS­97240­79­4­Market­Unimark­Remedies­India­Janssen­Pharmaceutica­Belgium­Taj­Pharmaceuticals­India.html Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here:

Delete press release

Edit press release

http://www.openpr.com/news/383520/Global­Topiramate­CAS­97240­79­4­Market­Unimark­Remedies­India­Janssen­Pharmaceutica­Belgium­Taj­Phar…

1/2


12/10/2016 Global Topiramate (CAS 97240­79­4) Market­Unimark Remedies (India), Janssen Pharmaceutica (Belgium), Taj Pharmaceuticals (India) ­ openPR To top

© openPR 2016 | Imprint

http://www.openpr.com/news/383520/Global­Topiramate­CAS­97240­79­4­Market­Unimark­Remedies­India­Janssen­Pharmaceutica­Belgium­Taj­Phar…

2/2


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.